There is no RationalWiki without you. We are a small non-profit with no staff – we are hundreds of volunteers who document pseudoscience and crankery around the world every day. We will never allow ads because we must remain independent. We cannot rely on big donors with corresponding big agendas. We are not the largest website around, but we believe we play an important role in defending truth and objectivity.
If everyone who saw this today donated $5, we would meet our goal for 2019.
| Fighting pseudoscience isn't free.|
We are 100% user-supported! Help and donate $5, $20 or whatever you can today with !
Activase (generic name Alteplase) is a drug produced by Genentech, a Roche Group member, that is indicated for the treatment of acute Ischemic Stroke.
It is currently being studied by both Genentech and independent cancer research projects as a treatment for particular types of cancer with promising but as yet inconclusive results. It is also being used for cancer patients because of its side effect of preventing plaque in and around tissue with ports or shunts or chronic bleeding from tissue resistant to healing. It is FDA approved for use with heart attacks and strokes.